Non-Billable / Non-Specific Code
ICD-10-CM C22 is the diagnosis code for Malignant neoplasm of liver and intrahepatic bile ducts. This code falls under the section "Malignant neoplasms of digestive organs" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions should never be coded at the same time as C22. They are mutually exclusive:
Understanding where C22 sits in the ICD-10-CM classification helps ensure proper coding:
No, C22 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
C22 is the ICD-10-CM diagnosis code for "Malignant neoplasm of liver and intrahepatic bile ducts". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
C22 is located in Section C15-C26 — "Malignant neoplasms of digestive organs" within Chapter 2 of the ICD-10-CM Tabular List.
C22 has 8 sub-code(s) that provide more specific detail: C22.0, C22.1, C22.2, C22.3, C22.4 and more.
Use C22 when the patients documented diagnosis matches "Malignant neoplasm of liver and intrahepatic bile ducts" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant neoplasm of liver and intrahepatic bile ducts is C22.
No, C22 is non-billable. Use a more specific sub-code for primary diagnosis billing.
C22 is in Chapter 2 of the ICD-10-CM Tabular List.
Type 1 Excludes for C22 include: malignant neoplasm of biliary tract NOS (C24.9); secondary malignant neoplasm of liver and intrahepatic bile duct (C78.7).
Yes, C22 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.